Delivery Order SPE2DB20D1110-SPE2DB24FJ74H

Award Date 11/14/23
Potential Completion Date 11/15/23
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Escitalopram 20 mg tablets to the Defense Logistics Agency (DLA). The $1,231.94 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 17, 2023, with a completion date of May 18, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Escitalopram 10 mg tablets. The $1,766.55 firm fixed-price delivery order contract has a completion date of February 20, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,314.62 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company, for the provision of Escitalopram 10 mg tablets. This award is part of Amerisourcebergen's broader indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, for the delivery of pharmaceutical products and medical supplies to military treatment facilities. The IDC, which does not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,863.85 firm fixed-price delivery order is for the supply of 500 units of the medication Escitalopram 5 mg tablet. The contract has an ultimate completion date of July 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,065.18 firm-fixed-price delivery order is for the supply of Escitalopram 10 mg tablets, with a completion date of June 8, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $4,427.35 firm fixed-price delivery order contract is for the provision of escitalopram 5 mg tablets. The contract has an ultimate completion date of November 29, 2023 and is not associated with any set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.34 firm-fixed-price delivery order is for the supply of 1,000 tablets of the generic drug Escitalopram 10 mg. The contract has a completion date of November 21, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,007.39 firm fixed-price delivery order is for the supply of 4,560,955,982 units of 10 mg Escitalopram tablets. The contract has an ultimate completion date of May 17, 2023 and was awarded on May 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,371.94 firm-fixed-price delivery order is for the supply of 4,561,154,848 units of Escitalopram 20 mg tablets. The contract has an ultimate completion date of June 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Escitalopram 20 mg tablets. The contract has a firm fixed price of $6,369.00 and a completion date of January 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB24FJ74H
    Delivery Order

This contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of escitalopram 20 mg tablets. The $1,662.13 firm fixed-price delivery order has a completion date of November 15, 2023. The award is not designated as a set-aside contract.

Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally. The company also has a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracting mechanisms enable efficient government procurement of essential pharmaceutical and medical commodities for military personnel, veterans, and other federal beneficiaries.

Generated 5/12/25, 10:45 AM